Luther King Capital Management (LKCM)
MEDP icon

Luther King Capital Management (LKCM)’s Medpace MEDP Stock Holding History

Luther King Capital Management (LKCM)’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3M Buy
23,307
+1,419
+6% +$655K 0.05% 166
2026
Q1 		$10.5M Buy
21,888
+3,557
+19% +$1.82M 0.05% 169
2025
Q4 		$10.3M Buy
18,331
+739
+4% +$419K 0.04% 175
2025
Q3 		$9.05M Sell
17,592
-3,269
-16% -$1.43M 0.04% 181
2025
Q2 		$6.55M Buy
20,861
+311
+2% +$93.4K 0.03% 205
2025
Q1 		$6.26M Buy
20,550
+10
+0% +$3.36K 0.03% 202
2024
Q4 		$6.82M Buy
20,540
+3,324
+19% +$1.13M 0.03% 198
2024
Q3 		$5.75M Buy
17,216
+1,619
+10% +$615K 0.02% 208
2024
Q2 		$6.42M Hold
15,597
– – 0.03% 195
2024
Q1 		$6.3M Hold
15,597
– – 0.03% 197
2023
Q4 		$4.78M Hold
15,597
– – 0.02% 211
2023
Q3 		$3.78M Buy
15,597
+563
+4% +$144K 0.02% 227
2023
Q2 		$3.61M Buy
15,034
+328
+2% +$68.1K 0.02% 256
2023
Q1 		$2.77M Sell
14,706
-45
-0.3% -$9.31K 0.01% 275
2022
Q4 		$3.13M Sell
14,751
-734
-5% -$147K 0.02% 244
2022
Q3 		$2.43M Sell
15,485
-9,425
-38% -$1.5M 0.01% 270
2022
Q2 		$3.73M Sell
24,910
-4,755
-16% -$688K 0.02% 209
2022
Q1 		$4.85M Sell
29,665
-5,575
-16% -$919K 0.02% 200
2021
Q4 		$7.67M Hold
35,240
– – 0.03% 161
2021
Q3 		$6.67M Sell
35,240
-10
-0% -$1.82K 0.03% 169
2021
Q2 		$6.23M Sell
35,250
-515
-1% -$88.9K 0.03% 184
2021
Q1 		$5.87M Sell
35,765
-990
-3% -$151K 0.03% 183
2020
Q4 		$5.12M Sell
36,755
-860
-2% -$108K 0.03% 181
2020
Q3 		$4.2M Sell
37,615
-1,900
-5% -$220K 0.03% 183
2020
Q2 		$3.68M Buy
39,515
+3,305
+9% +$281K 0.03% 190
2020
Q1 		$2.66M Sell
36,210
-2,295
-6% -$199K 0.02% 198
2019
Q4 		$3.24M Buy
38,505
+8,345
+28% +$646K 0.02% 225
2019
Q3 		$2.54M Buy
+30,160
New +$2.28M 0.02% 246

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Luther King Capital Management (LKCM)'s MEDP Position: Q2 2026 in Review

Luther King Capital Management (LKCM) increased its Medpace (MEDP) stake by 6.5% in Q2 2026, buying an estimated $655K and bringing the position to 23,307 shares worth $12.3M. The position accounts for 0.05% of the portfolio, ranked #166.

Luther King Capital Management (LKCM) first reported a position in MEDP in Q3 2019 and has held it in 28 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Luther King Capital Management (LKCM) held 23,307 shares of Medpace worth $12.3M as of Q2 2026.
  • Luther King Capital Management (LKCM) bought 1,419 Medpace shares in Q2 2026, an estimated $655K.
  • Medpace made up 0.05% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #166 holding.
  • Luther King Capital Management (LKCM) first reported a position in Medpace in Q3 2019 and has held it in 28 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.